Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Swetha K. Godavarthi has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Transsynaptic Bridges: Molecular Architects of Synaptic Identity, Plasticity and Disease

    by Swetha K. Godavarthi

    Transsynaptic bridges are molecular complexes spanning the synaptic cleft that physically couple presynaptic release machinery to postsynaptic receptor fields. That this architecture is the direct target of autoimmune attack in myasthenia gravis and a primary locus of genetic risk in autism spectrum disorder and schizophrenia underscores that transsynaptic bridges are not only important during synapse development but are continuously required organizers of neural function. This review traces the evolution of structural, molecular, and functional evidence that shaped our understanding of the synapse as a single integrated trans-cellular unit. Several defining properties of a synapse emerge as a consequence of transsynaptic bridges—for example, the nanoscale alignment they impose between vesicle fusion sites and receptor nanodomains determines transmission efficacy, the bidirectional communication they coordinate across the cleft drives signaling specificity, and they undergo activity-dependent remodeling, thereby physically encoding synaptic history.

  • Open Access

    Drug-induced change in transmitter identity is a shared mechanism generating cognitive deficits

    by Marta Pratelli, Anna M. Hakimi, Arth Thaker, Hyeonseok Jang, Hui-Quan Li, Swetha K. Godavarthi, Byung Kook Lim, Nicholas C. Spitzer

    Cognitive deficits are long-lasting consequences of drug use, yet the convergent mechanism by which classes of drugs with different pharmacological properties cause similar deficits is unclear. We find that both phencyclidine and methamphetamine, despite differing in their targets in the brain, cause the same glutamatergic neurons in the medial prefrontal cortex of male mice to gain a GABAergic phenotype and decrease expression of their glutamatergic phenotype. Suppressing drug-induced gain of GABA with RNA-interference prevents appearance of memory deficits. Stimulation of dopaminergic neurons in the ventral tegmental area is necessary and sufficient to produce this gain of GABA. Drug-induced prefrontal hyperactivity drives this change in transmitter identity. Returning prefrontal activity to baseline, chemogenetically or with clozapine, reverses the change in transmitter phenotype and rescues the associated memory deficits. This work reveals a shared and reversible mechanism that regulates the appearance of cognitive deficits upon exposure to different drugs.


  • Open Access

    Embryonic exposure to environmental factors drives transmitter switching in the neonatal mouse cortex causing autistic-like adult behavior

    by Swetha K. Godavarthi, Hui-Quan Li, Marta Pratelli, Nicholas C. Spitzer

    Autism spectrum disorders (ASD) can be caused by environmental factors. These factors act early in the development of the nervous system and induce stereotyped repetitive behaviors and diminished social interactions, among other outcomes. Little is known about how these behaviors are produced. In pregnant women, delivery of valproic acid (VPA) (to control seizure activity or stabilize mood) or immune activation by a virus increases the incidence of ASD in offspring. We found that either VPA or Poly Inosine:Cytosine (which mimics a viral infection), administered at mouse embryonic day 12.5, induced a neurotransmitter switch from GABA to glutamate in PV- and CCK-expressing interneurons in the medial prefrontal cortex by postnatal day 10. The switch was present for only a brief period during early postnatal development, observed in male and female mice at postnatal day 21 and reversed in both males and females by postnatal day 30. At postnatal day 90, male mice exhibited stereotyped repetitive behaviors and diminished social interaction while female mice exhibited only stereotyped repetitive behavior. Transfecting GAD1 in PV- and CCK-expressing interneurons at postnatal day 10, to reintroduce GABA expression, overrode the switch and prevented expression of autistic-like behavior. These findings point to an important role of neurotransmitter switching in mediating the environmental causes of autism.


  • Top Cited Papers

    Generalized fear after acute stress is caused by change in neuronal cotransmitter identity

    by Hui-Quan Li, Wuji Jiang, Li Ling, Marta Pratelli, Cong Chen, Vaidehi Gupta, Swetha K. Godavarthi, Nicholas C. Spitzer

    Overgeneralization of fear to harmless situations is a core feature of anxiety disorders resulting from acute stress, yet the mechanisms by which fear becomes generalized are poorly understood. In this study, we show that generalized fear in mice results from a transmitter switch from glutamate to γ-aminobutyric acid (GABA) in serotonergic neurons of the lateral wings of the dorsal raphe. Similar change in transmitter identity was found in the postmortem brains of individuals with posttraumatic stress disorder (PTSD). Overriding the transmitter switch in mice prevented the acquisition of generalized fear. Corticosterone release and activation of glucocorticoid receptors mediated the switch, and prompt antidepressant treatment blocked the cotransmitter switch and generalized fear. Our results provide important insight into the mechanisms involved in fear generalization.


  • Open Access

    Drug-induced change in transmitter identity is a shared mechanism generating cognitive deficits

    by Nicholas Spitzer, Marta Pratelli, Anna Hakimi, Arth Thaker, Hui-Quan Li, Swetha Godavarthi

    Cognitive deficits are a long-lasting consequence of drug use, yet the convergent mechanism by which classes of drugs with different pharmacological properties cause similar deficits is unclear. We find that both phencyclidine and methamphetamine, despite differing in their targets in the brain, cause the same glutamatergic neurons in the medial prefrontal cortex to gain a GABAergic phenotype and decrease their expression of the vesicular glutamate transporter. Suppressing the drug-induced gain of GABA with RNA-interference prevents the appearance of memory deficits. Stimulation of dopaminergic neurons in the ventral tegmental area is necessary and sufficient to produce this gain of GABA. Drug-induced prefrontal hyperactivity drives this change in transmitter identity. Returning prefrontal activity to baseline, chemogenetically or with clozapine, reverses the change in transmitter phenotype and rescues the associated memory deficits. The results reveal a shared and reversible mechanism that regulates the appearance of cognitive deficits upon exposure to different drugs.

  • Open Access

    Generalized fear following acute stress is caused by change in co-transmitter identity of serotonergic neurons

    by Hui-Quan Li, Wuji Jiang, Lily Ling, Vaidehi Gupta, Cong Chen, Marta Pratelli, Swetha K. Godavarthi, Nicholas C. Spitzer

    Overgeneralization of fear to harmless situations is a core feature of anxiety disorders resulting from acute stress, yet the mechanisms by which fear becomes generalized are poorly understood. Here we show that generalized fear in mice in response to footshock results from a transmitter switch from glutamate to GABA in serotonergic neurons of the lateral wings of the dorsal raphe. We observe a similar change in transmitter identity in the postmortem brains of PTSD patients. Overriding the transmitter switch in mice using viral tools prevents the acquisition of generalized fear. Corticosterone release and activation of glucocorticoid receptors trigger the switch, and prompt antidepressant treatment blocks the co-transmitter switch and generalized fear. Our results provide new understanding of the plasticity involved in fear generalization. One sentence summary Acute stress produces generalized fear by causing serotonergic neurons to switch their co-transmitter from glutamate to GABA


  • Open Access

    Postsynaptic receptors regulate presynaptic transmitter stability through trans-synaptic bridges

    by Swetha K. Godavarthi, Masateru Hiramoto, Yuri Ignatyev, Jacqueline B. Levin, Hui-Quan Li, Marta Pratelli, Jennifer Borchardt, Cynthia M Czajkowski, Laura N. Borodinsky, Lora Sweeney, et al.

    Stable matching of neurotransmitters with their receptors is fundamental to synapse function, to achieve reliable and robust communication in neural circuits. Presynaptic neurotransmitters regulate selection of postsynaptic transmitter receptors. However, whether postsynaptic receptors regulate selection of presynaptic transmitters is unknown. Here we show that blockade of postsynaptic acetylcholine receptors at the neuromuscular junction leads to loss of the cholinergic phenotype in motor neurons and stabilization of an earlier, developmentally transient glutamatergic phenotype. Exogenous postsynaptic expression of GABA A receptors leads to the stabilization of an earlier, developmentally transient GABAergic motor neuron phenotype. Both acetylcholine receptors and GABA receptors are linked to presynaptic neurons through trans-synaptic bridges. Knock-down of different components of these trans-synaptic bridges prevents stabilization of the cholinergic and GABAergic phenotypes. We conclude that this bidirectional communication enforces a match between transmitter and receptor and ensures the fidelity of synaptic transmission. Our findings suggest a role of dysfunctional transmitter receptors in neurological disorders that involve the loss of the presynaptic transmitter.

  • Open Access

    Drug-induced change in transmitter identity is a shared mechanism generating cognitive deficits

    by Pratelli Marta, Anna M. Hakimi, Arth Thaker, Hui-Quan Li, Swetha K. Godavarthi, Nicholas C. Spitzer

    Cognitive deficits are a long-lasting consequence of drug use, yet the convergent mechanism by which classes of drugs with different pharmacological properties cause similar deficits is unclear. We find that both phencyclidine and methamphetamine, despite differing in their targets in the brain, impair memory by causing the same glutamatergic neurons in the medial prefrontal cortex to gain a GABAergic phenotype and decrease their expression of the vesicular glutamate transporter. Suppressing drug-induced gain of GABA with RNA-interference prevents the appearance of memory deficits. Drug-induced prefrontal hyperactivity drives this change in transmitter identity. Normalizing the activity of prefrontal glutamatergic neurons after drug-exposure reverses the gain of GABAergic phenotype and rescues the associated memory deficits. Increased activity of dopaminergic neurons in the ventral tegmental area is necessary and sufficient to produce the change in transmitter identity. The results reveal a shared and reversible mechanism by which exposure to different drugs causes cognitive deficits.


  • Open Access

    Decoding Neurotransmitter Switching: The Road Forward

    by Hui-Quan Li, Marta Pratelli, Swetha Godavarthi, Stefania Zambetti, Nicholas C. Spitzer

    Neurotransmitter switching is a form of brain plasticity in which an environmental stimulus causes neurons to replace one neurotransmitter with another, often resulting in changes in behavior. This raises the possibility of applying a specific environmental stimulus to induce a switch that can enhance a desirable behavior or ameliorate symptoms of a specific pathology. For example, a stimulus inducing an increase in the number of neurons expressing dopamine could treat Parkinson's disease, or one affecting the number expressing serotonin could alleviate depression. This may already be producing successful treatment outcomes without our knowing that transmitter switching is involved, with improvement of motor function through physical activity and cure of seasonal depression with phototherapy. This review presents prospects for future investigation of neurotransmitter switching, considering opportunities and challenges for future research and describing how the investigation of transmitter switching is likely to evolve with new tools, thus reshaping our understanding of both normal brain function and mental illness.